Abbott Laboratories ABT NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score

80/100

5/7 Pass

SharesGrow Intrinsic Value

Abbott Laboratories (ABT) 報告總資產為 $86.71B 總負債為 $33.94B 財年 2025, 總權益為 $52.77B.

公司持有 $8.94B 現金及短期投資. 總債務為 $15.07B, 淨債務為 $6.55B. D/E比率為 0.29 (保守的).

流動比率為 1.58, 表明短期流動性強. 利息覆蓋率為 23.6x (強勁的).

本頁支持的標準:

HEALTH (100/100, Pass) — Debt-to-Equity of 0.29, current ratio of 1.58, interest coverage 23.6x — 資產負債表強勁
MOAT (86/100) — 總資產 $86.71B 和 equity $52.77B 支持公司的競爭規模
VALUE (58/100) — Debt-to-Equity 0.29 影響整體估值風險評估

SharesGrow 綜合評分: 80/100 其中 5/7 項標準通過.

SharesGrow 7-Criteria Score

80/100

SG Score

View full scorecard →

價值

58/100

Price-to-Earnings & upside

→ Valuation

✓

未來

85/100

Analyst consensus

→ Forecast

✓

過去

100/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

Proven by this page

✓

護城河

86/100

→ Income

✓

成長

73/100

→ Income

收入

55/100

→ Income

Abbott Laboratories 資產負債表歷史

指標	FY2025	FY2024	FY2023	FY2022
總資產	$86.71B	$81.41B	$73.21B	$74.44B
Total Liabilities	$33.94B	$33.51B	$34.39B	$37.53B
總債務	$15.07B	$15.02B	$15.87B	$17.72B
Cash & Investments	$8.94B	$7.97B	$7.28B	$10.17B
股東權益總計	$52.13B	$47.66B	$38.6B	$36.69B